Insider Cluster (1 insider) ·Filed Feb 23, 2026

ARVN

ARVINAS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago
Insider cluster: 4 insiders, $0.1M total
Actionable Insight • Neutral

The level of insider selling is minimal and not concentrated, suggesting no strong negative signal. Traders should monitor for any escalation in selling volume or participation by C-suite executives.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ARVN ▼ -28.62% at T+60d
NEUTRAL call ✗ call lost -28.62% · α vs SPY -36.87% · entry $12.30 → $8.78
Entry anchored
Feb 20, 03:59 PM ET
via exchange tick
T+1d
+0.57%
call +0.57% · α -0.17%
$12.37
settled 7mo ago
T+5d
+8.86%
call +8.86% · α +8.24%
$13.39
settled 7mo ago
T+20d
-16.10%
call -16.10% · α -12.15%
$10.32
settled 7mo ago
T+60d
-28.62%
call -28.62% · α -36.87%
$8.78
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

An insider at Arvinas, Inc. (ARVN) sold 4,688 shares in an open-market transaction, generating proceeds of approximately $62,069. This brings the total insider selling over the past 30 days to $101K. The transaction is small relative to the company's $849M market cap and appears consistent with routine, pre-planned trading activity.

Key Financial Metrics

Direction
selling
Total Value
$62.1K
Insiders
1

Key Facts

  • Insider Houston John G sold 4,688 shares at $13.24 per share for total proceeds of $62,069.12
  • This was an open-market sale (Form 4 code 'S')
  • Total insider selling over the past 30 days amounts to $101K across 4 transactions
  • The total value of recent insider sales is less than 0.01% of Arvinas' $849M market capitalization

Financial Impact

$62,069 in open-market sales by one insider; $101K total over 30 days

insider ownershipshare count

Risk Factors

  • Continued insider selling, even at low levels, could signal muted confidence in near-term prospects
  • Biotech stocks like ARVN are inherently volatile and sensitive to clinical trial outcomes

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (1 trades, 7d window)cluster-ARVN-1772503070312
18 reports for ARVN
Performance horizon
100% Hit rate 9 of 9 directional calls best @ T+60▲ +28.62%Feb 23, 2026
Filters
Rows
Reports for ARVN — sortable, filterable
TypeNow
Sep 4, 2026
28d ago
144
NEUTRAL ★ 3/10
$9.08 $8.26▼ −9.03%▼ −7.91%$7.41 (−18.39%)
Jun 22, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$8.14 $8.29▲ +1.84%▲ +0.83%$7.41 (−8.97%)
Jun 2, 2026
17w ago
8-K
BEARISH ★ 6/10
$7.70 $6.98▲ +9.35%▲ +5.53%$7.41 (+3.77%)
May 12, 2026
20w ago
8-K
MIXED ★ 6/10
$9.57 $8.78▼ −8.26%▼ −8.33%$7.41 (−22.57%)
May 12, 2026
20w ago
8-K
BULLISH ★ 7/10
$9.57 $8.78▼ −8.26%▼ −8.33%$7.41 (−22.57%)
May 12, 2026
20w ago
Press Release
BEARISH ★ 8/10
$9.57 $8.78▲ +8.26%▲ +8.33%$7.41 (+22.57%)
May 8, 2026
20w ago
144
NEUTRAL ★ 2/10
$9.66 $8.78▼ −9.11%▼ −9.02%$7.41 (−23.29%)
May 8, 2026
20w ago
144
NEUTRAL ★ 2/10
$9.66 $8.78▼ −9.11%▼ −9.02%$7.41 (−23.29%)
May 5, 2026
21w ago
Press Release
BEARISH ★ 7/10
$10.61 $9.57▲ +9.80%▲ +11.79%$7.41 (+30.16%)
May 1, 2026
22w ago
8-K
BULLISH ★ 8/10
$10.51 $10.19▼ −3.04%▼ −5.39%$7.41 (−29.50%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (64h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 3, 2026